Solid-phase synthesis of smac peptidomimetics incorporating triazoloprolines and biarylalanines

Sebastian T Le Quement1, Mette Ishoey, Mette T Petersen

  • 1Department of Chemistry, Technical University of Denmark.

ACS Combinatorial Science
|September 13, 2011
PubMed

Insights

Researchers synthesized Smac-derived tetrapeptide libraries using solid-phase methods. Structural modifications to the AVPF sequence significantly enhanced cytotoxicity toward cancer cells, offering new pro-apoptotic compound development strategies.

Area of Science:

  • Medicinal Chemistry
  • Molecular Biology
  • Biochemistry

Background:

  • Apoptosis is vital for multicellular organism homeostasis.
  • Cancer cells often downregulate apoptotic pathways, partly due to inhibitors of apoptosis proteins (IAPs).
  • Smac protein antagonizes IAPs, suggesting potential for new pro-apoptotic drug development.

Purpose of the Study:

  • To develop a solid-phase synthesis for Smac-derived tetrapeptide libraries.
  • To explore the impact of structural modifications on the AVPF sequence for pro-apoptotic activity.

Main Methods:

  • Solid-phase synthesis of tetrapeptide libraries based on the (N-Me)AVPF sequence.
  • Incorporation of triazoloprolines and biarylalanines using Cu(I)-catalyzed azide-alkyne cycloaddition and Pd-catalyzed Suzuki cross-coupling.
  • Optimization of solid-phase procedures for high purity and yield (>90%).

Main Results:

  • Efficient solid-phase synthesis of Smac-derived tetrapeptide libraries achieved.
  • All synthesized peptides exhibited excellent crude purity and yield.
  • Biological evaluation demonstrated that structural modifications on the AVPF sequence are crucial for cytotoxicity against HeLa cells.

Conclusions:

  • The developed solid-phase approach provides efficient access to Smac-derived tetrapeptide libraries.
  • Structural decorations on the AVPF sequence significantly influence cytotoxicity.
  • These findings support the development of novel pro-apoptotic compounds targeting cancer therapy.